State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
Frequently Asked Questions — Clinical Trials in North Carolina
How many clinical trials are currently recruiting in North Carolina?
ClinicalMetric currently tracks 396 actively recruiting clinical trials with at least one location in North Carolina. The total number of registered studies—including active but not currently enrolling trials—is 396. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Carolina?
North Carolina hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Carolina?
To join a clinical trial in North Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in North Carolina
NCT05907629 N/A
Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vasc...
Condition
Stroke
Enrollment
300 pts
Location
United States
Sponsor
Yale University
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT06158139 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Condition
Pancreas Cancer
Enrollment
27 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT04378439 N/A
Recruiting
Appalachian Partnership to Reduce Disparities (Aim 2)
Condition
HIV/AIDS
Enrollment
141 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
290 pts
Location
United States
Sponsor
Incyte Corporation
NCT06708949 Phase 2
Recruiting
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivoluma...
Condition
Renal Cell Carcinoma, Clear Cell
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
NCT05317858 Phase 3
Recruiting
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standar...
Condition
Brain Tumor
Enrollment
30 pts
Location
United States, Canada, South Korea
Sponsor
InSightec
NCT06812078 Phase 2
Recruiting
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Condition
Idiopathic Hypersomnia
Enrollment
96 pts
Location
United States, France, Hong Kong
Sponsor
Takeda
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
NCT07117708 N/A
Recruiting
Optimizing Timing of Cesarean Delivery Consent on Labor and Delivery
Condition
Pregnancy
Enrollment
200 pts
Location
United States
Sponsor
Duke University
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06880055 N/A
Recruiting
Shield Post-Approval Study Protocol
Condition
Colo-rectal Cancer
Enrollment
3,375 pts
Location
United States
Sponsor
Guardant Health, Inc.
NCT05145491 N/A
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Condition
Epiretinal Membrane
Enrollment
400 pts
Location
United States, United Kingdom
Sponsor
Jaeb Center for Health Researc
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT05365581 Phase 1
Recruiting
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adul...
Condition
Gastric Adenocarcinoma
Enrollment
398 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05603728 N/A
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Condition
Osteo Arthritis Shoulders
Enrollment
20,000 pts
Location
United States, Canada, France
Sponsor
Exactech
NCT06685757 Phase 3
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in A...
Condition
Antibody-mediated Rejection
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
NCT05646381 Phase 2
Recruiting
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacar...
Condition
Aortic Stenosis
Enrollment
502 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT07281430 N/A
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Tri...
Condition
Cervical Carcinoma
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07220512 N/A
Recruiting
The Better, Harder, Faster, Stronger Study
Condition
Frailty at Older Adults
Enrollment
35 pts
Location
United States
Sponsor
Wake Forest University Health
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology